Cooper Companies, Inc. COO
We take great care to ensure that the data presented and summarized in this overview for COOPER COMPANIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding COO
View all-
Intermede Investment Partners LTD1.09MShares$99.2 Million2.52% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8143KShares$12.9 Million0.07% of portfolio
-
Brant Point Investment Management LLC New York, NY109KShares$9.88 Million2.96% of portfolio
-
Eaton Vance Management Boston, MA86.1KShares$7.81 Million0.03% of portfolio
-
Crystal Rock Capital Management54.2KShares$4.91 Million3.65% of portfolio
-
Wd Rutherford LLC39KShares$3.53 Million2.12% of portfolio
-
Cibc World Markets Corp New York, NY27KShares$2.45 Million0.02% of portfolio
-
Polaris Wealth Advisory Group, LLC5.83KShares$528,8450.14% of portfolio
-
Ferguson Wellman Capital Management, Inc3.34KShares$302,8710.01% of portfolio
-
Allstate Investment Management CO Northbrook, IL3.03KShares$274,7600.03% of portfolio
Latest Institutional Activity in COO
Top Purchases
Top Sells
About COO
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Transactions at COO
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 08
2025
|
Nicholas Khadder VP, General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,863
-23.57%
|
$169,533
$91.88 P/Share
|
Jan 08
2025
|
Nicholas Khadder VP, General Counsel & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
3,492
+35.55%
|
-
|
Jan 08
2025
|
Brian G Andrews EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,343
-13.74%
|
$304,213
$91.88 P/Share
|
Jan 08
2025
|
Brian G Andrews EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,420
+22.31%
|
-
|
Jan 08
2025
|
Daniel G Mc Bride EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,514
-4.32%
|
$410,774
$91.88 P/Share
|
Jan 08
2025
|
Daniel G Mc Bride EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,728
+7.86%
|
-
|
Jan 08
2025
|
Agostino Ricupati SVP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,360
-13.55%
|
$214,760
$91.88 P/Share
|
Jan 08
2025
|
Agostino Ricupati SVP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,472
+21.56%
|
-
|
Jan 08
2025
|
Holly R Sheffield President, CSI |
SELL
Payment of exercise price or tax liability
|
Direct |
2,364
-3.89%
|
$215,124
$91.88 P/Share
|
Jan 08
2025
|
Holly R Sheffield President, CSI |
BUY
Exercise of conversion of derivative security
|
Direct |
4,900
+7.56%
|
-
|
Jan 08
2025
|
Gerard H Warner Iii President, CooperVision, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,894
-4.75%
|
$627,354
$91.88 P/Share
|
Jan 08
2025
|
Gerard H Warner Iii President, CooperVision, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
13,328
+9.66%
|
-
|
Jan 08
2025
|
Albert G White Iii President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,386
-5.11%
|
$854,126
$91.88 P/Share
|
Jan 08
2025
|
Albert G White Iii President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,340
+9.08%
|
-
|
Sep 19
2024
|
Albert G White Iii President & CEO |
SELL
Open market or private sale
|
Direct |
114,992
-21.2%
|
$12,649,120
$110.92 P/Share
|
Sep 19
2024
|
Albert G White Iii President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
114,992
+29.09%
|
$4,944,656
$43.83 P/Share
|
Sep 10
2024
|
Agostino Ricupati SVP & CAO |
SELL
Open market or private sale
|
Direct |
1,601
-24.94%
|
$172,908
$108.03 P/Share
|
Sep 05
2024
|
Brian G Andrews EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
24,788
-78.94%
|
$2,602,740
$105.9 P/Share
|
Sep 05
2024
|
Brian G Andrews EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,788
+33.34%
|
$941,944
$38.37 P/Share
|
Sep 04
2024
|
Daniel G Mc Bride EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
114,992
-31.2%
|
$12,189,152
$106.18 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 631K shares |
---|---|
Bona fide gift | 5.18K shares |
Payment of exercise price or tax liability | 31.8K shares |
---|---|
Open market or private sale | 553K shares |
Bona fide gift | 35.2K shares |